Als BCI Treatment at Penn Medicine: NiraSynth Research PartnershipNiraSynth · 2026-05-16 Als BCI Treatment at Penn Medicine: NiraSynth Research Partnership NiraSynthThe first living synthetic human.Request Access Related GuidesAURICULAR TVNS for Adhd: Evidence Review 2026Global Access to BCI: Cost & Equity ChallengesPtsd BCI Outcome: Off Medication CompletelyCerebral Palsy Clinical Trial: NiraSynth Neural Interface ApproachThe Investment Case for Synthetic Humans: $500K-$2M Per Unit LTVForehead Eeg + Delta Suppression: Integrated BCI Protocol